Phase 4 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People whose doctors expect them to live for more than 3 months
- People who are reasonably active and able to care for themselves, with limited physical restrictions from their illness (confirm with trial site)
- People diagnosed with invasive breast cancer confirmed by a tissue sample test
- People who are planned to receive one of the following chemotherapy combinations: TAC, TC, or TCbH (confirm with trial site for what these mean in your situation)
- People whose blood, liver, lung, and kidney are functioning well enough to meet the trial's requirements
- People who have signed a consent form agreeing to take part in the trial
Who may not be able to join:
- People with a known allergic reaction to rhG-CSF or PEG-rhG-CSF (types of white blood cell booster medications)
- People who are pregnant or currently breastfeeding
- People who have had a previous cancer that has not been fully treated or cured
- People who have received chemotherapy or radiotherapy within the 4 weeks before joining the trial
- People who have received PEG-rhG-CSF within the 6 weeks before joining the trial
- People who have had an uncontrolled infectious disease within the 2 weeks before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13256715221
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of febrile neutropenia for chemotherapy cycle 1.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.